JPWO2021251453A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021251453A5
JPWO2021251453A5 JP2022530615A JP2022530615A JPWO2021251453A5 JP WO2021251453 A5 JPWO2021251453 A5 JP WO2021251453A5 JP 2022530615 A JP2022530615 A JP 2022530615A JP 2022530615 A JP2022530615 A JP 2022530615A JP WO2021251453 A5 JPWO2021251453 A5 JP WO2021251453A5
Authority
JP
Japan
Prior art keywords
lipid
particle
cov
sars
coronavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022530615A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021251453A1 (https=
JP7672657B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/022057 external-priority patent/WO2021251453A1/ja
Publication of JPWO2021251453A1 publication Critical patent/JPWO2021251453A1/ja
Publication of JPWO2021251453A5 publication Critical patent/JPWO2021251453A5/ja
Priority to JP2025044691A priority Critical patent/JP2025094115A/ja
Application granted granted Critical
Publication of JP7672657B2 publication Critical patent/JP7672657B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022530615A 2020-06-11 2021-06-10 核酸脂質粒子ワクチン Active JP7672657B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025044691A JP2025094115A (ja) 2020-06-11 2025-03-19 核酸脂質粒子ワクチン

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020101420 2020-06-11
JP2020101420 2020-06-11
JP2021033278 2021-03-03
JP2021033278 2021-03-03
PCT/JP2021/022057 WO2021251453A1 (ja) 2020-06-11 2021-06-10 核酸脂質粒子ワクチン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025044691A Division JP2025094115A (ja) 2020-06-11 2025-03-19 核酸脂質粒子ワクチン

Publications (3)

Publication Number Publication Date
JPWO2021251453A1 JPWO2021251453A1 (https=) 2021-12-16
JPWO2021251453A5 true JPWO2021251453A5 (https=) 2024-06-13
JP7672657B2 JP7672657B2 (ja) 2025-05-08

Family

ID=78846062

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022530615A Active JP7672657B2 (ja) 2020-06-11 2021-06-10 核酸脂質粒子ワクチン
JP2025044691A Pending JP2025094115A (ja) 2020-06-11 2025-03-19 核酸脂質粒子ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025044691A Pending JP2025094115A (ja) 2020-06-11 2025-03-19 核酸脂質粒子ワクチン

Country Status (7)

Country Link
US (1) US20230248819A1 (https=)
EP (1) EP4166158A4 (https=)
JP (2) JP7672657B2 (https=)
KR (1) KR20230024261A (https=)
CN (1) CN115605221A (https=)
TW (1) TWI907439B (https=)
WO (1) WO2021251453A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12409219B2 (en) 2020-06-30 2025-09-09 Boost Biopharma, Inc. Recombinant polypeptides containing at least one immunogenic fragment and uses thereof
GB202119115D0 (en) * 2021-12-30 2022-02-16 Fondo Ricerca Medica S R I Vaccine
US20250109173A1 (en) * 2021-12-31 2025-04-03 Boost Biopharma, Inc. Recombinant polypeptides containing at least one immunogenic fragment and antibody fc region and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201534578A (zh) * 2013-07-08 2015-09-16 Daiichi Sankyo Co Ltd 新穎脂質
PL4023249T3 (pl) * 2014-04-23 2025-03-10 Modernatx, Inc. Szczepionki z kwasem nukleinowym
JP2020101420A (ja) 2018-12-21 2020-07-02 パナソニックIpマネジメント株式会社 透過度検知装置
CN110361853B (zh) 2019-08-16 2021-08-20 诚瑞光学(常州)股份有限公司 摄像光学镜头
US20210228707A1 (en) * 2020-01-28 2021-07-29 Modernatx, Inc. Coronavirus rna vaccines

Similar Documents

Publication Publication Date Title
JPWO2021251453A5 (https=)
KR101168440B1 (ko) 지질 캡슐화된 간섭 rna
JP6792847B2 (ja) mRNAの機能化方法
JP2023546175A (ja) 脂質ナノ粒子製造の方法及びそれに由来する組成物
JP2021522248A (ja) 粒子状製剤用の凍結保護剤
JP2022518504A (ja) 閉端dna(cedna)ならびに遺伝子療法または核酸療法に関連する免疫応答を低減させる方法における使用
JP2022546597A (ja) 閉端dnaおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法
CN114404391B (zh) 一种纳米粒及其制备方法和用途
KR20240107146A (ko) 호흡기 세포융합 바이러스 rna 백신
JP2017536092A5 (https=)
CN1981044B (zh) 包封干扰rna的脂质
JP2011509258A5 (https=)
JP2012520082A5 (https=)
CN118159278A (zh) 单链可变片段(scFv)修饰的脂质纳米颗粒组合物及其用途
TWI853485B (zh) 核酸-脂質奈米粒子及使用其之方法
WO2022206734A1 (zh) 一种基因线路、rna递送系统及其应用
US20220288231A1 (en) Methods and compositions for reducing gene or nucleic acid therapy-related immune responses
TW202131945A (zh) 封入HPV mRNA之核酸脂質粒子疫苗
WO2024006863A1 (en) Lipid nanoparticle formulations for vaccines
CN116808191A (zh) 新型冠状病毒疫苗及其制备方法和应用
JP2024511808A (ja) ウイルスベクターに基づくrna送達システム及びその使用
JPWO2022244815A5 (https=)
CN120754284A (zh) 一种用于肝脏靶向联合递送CRISPR-Cas9系统和单链DNA修复模板的脂质纳米颗粒
JPWO2022244825A5 (https=)
WO2024022263A1 (zh) 脂质化合物和脂质纳米颗粒组合物